A standard operating procedure is attached to this page. This is based on the content of the NHSE/I letter ‘COVID-19 Vaccine Oxford AstraZeneca – movement of vaccine‘ of 7th January 2021, the NHSE/I ‘Position Statement around use of the Covid-19 Vaccine AstraZeneca (AZ) to vaccinate housebound patients‘ of 11th January 2021 and the Position Statement for the vaccination of Care Home residents using COVID-19 vaccine AstraZeneca (AZ). of 1st February 2021.
These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in Community Pharmacy settings.
You should also familiarise yourself with our background guide Facilitating pharmaceutical support to PCN designated sites for COVID-19 vaccinations before using this SOP.